abstract |
The invention relates to compounds which contain an antigen binding region which is bound to at least one enzyme which can metabolize a non or little cytotoxic compound (prodrug) into a cytotoxic compound (drug), the antigen binding region consisting of a single polypeptide chain. Advantageously, there are covalently bound carbohydrates on the polypeptide chain. |